InvestorsHub Logo
Followers 51
Posts 3078
Boards Moderated 0
Alias Born 05/11/2016

Re: None

Sunday, 01/29/2017 12:10:08 PM

Sunday, January 29, 2017 12:10:08 PM

Post# of 203913
AXIM after there efficacy results went .45 to a high of $6.00 check for yourself Oct 25-Oct 31 Last Year (700 Million Market Cap) ((OWCP less than 90 Million market with 2 products in 2017))

If you guys want your shares stolen from you go right ahead. The smart people will be scooping them up.


The Safety study is designed to test multiple escalating doses to determine the safety and tolerability of the medical grade cannabis cream on healthy volunteers. The psoriasis topical crème infused with active cannabinoids is a unique delivery-system product of OWC designed to be used for skin diseases, where the first application will be tested for safety and efficacy for Psoriasis. The efficacy studies have already been started and results are expected by the end of Jan 2017.


Now if you open and read this you can see it for yourself.




http://www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-to-submit-psoriasis-topical-cream-irb-safety-protocol-to-the-israeli-national-irb-helsinki-committee-601267666.html

$OWCP